2-Cyano-5-Flurobenzyl Bromide CAS 421552-12-7 Purity ≥99.0% (HPLC) Pabrik Panengah Trelagliptin Succinate
Pasokan Komérsial Panganteur Patali Trelagliptin Succinate:
6-Chloro-3-Methyluracil CAS 4318-56-3
2-Cyano-5-Flurobenzyl Bromide CAS 421552-12-7
(R)-(-)-3-Aminopiperidine Dihydrochloride CAS 334618-23-4
Trelagliptin Succinate panengah-int D CAS 865759-24-6
Trelagliptin Succinate CAS 1029877-94-8
Please contact: alvin@ruifuchem.com
| Ngaran Kimia | 2-Cyano-5-Flurobenzyl Bromide |
| sinonim | 2-(Bromométil)-4-Fluorobenzonitril |
| Nomer CAS | 421552-12-7 |
| Nomer CAT | RF-PI143 |
| Status saham | Dina Stok, Skala Produksi Nepi ka Ton |
| Formula Molekul | C8H5BrFN |
| Beurat Molekul | 214.03 |
| Titik Lebur | 67,0 nepi ka 71,0 ℃ |
| Sensitip | Sensitip Kelembapan |
| Kalarutan | Leyur dina Métanol |
| merek | Kimia Ruifu |
| Barang | spésifikasi |
| Penampilan | Bubuk bodas nepi ka Pareum-Konéng |
| Kamurnian / Métode Analisis | ≥99,0% (HPLC) |
| Kelembapan (KF) | ≤0,50% |
| Résidu on Ignition | ≤0,30% |
| Najis Tunggal | ≤0,50% |
| Total Kotoran | ≤1,00% |
| 1 H NMR Spéktrum | Konsisten Jeung Struktur |
| Standar tés | Standar Perusahaan |
| Pamakéan | Trelagliptin Succinate (CAS: 1029877-94-8) panengah |
Bungkusan: Botol, kantong Aluminium foil, kardus drum, 25kg / Drum, atawa nurutkeun sarat customer urang.
Kaayaan Panyimpenan:Simpen dina wadah anu disegel dina tempat anu tiis sareng garing;Ngajaga tina cahaya, Uap jeung infestation hama.
Shanghai Ruifu Chemical Co., Ltd. nyaéta produsén ngarah sareng supplier 2-Cyano-5-Flurobenzyl Bromide (CAS: 421552-12-7) kalayan kualitas luhur, seueur dianggo dina sintésis organik, sintésis perantara farmasi sareng bahan farmasi aktif. (API) sintésis.2-Cyano-5-Flurobenzyl Bromide tiasa dianggo dina sintésis Trelagliptin Succinate (CAS: 1029877-94-8).Trelagliptin Succinate mangrupikeun sambetan dipeptidyl peptidase-4 (DPP-4) anu selektif.Agén antidiabetik.Inhibitor DPP-4 sacara oral anu ngahasilkeun paningkatan anu signifikan sacara klinis sareng statistik dina kontrol glikemik dina pasien kalayan diabetes tipe 2.Trelagliptin Succinate disatujuan pikeun dianggo di Jepang dina Maret 2015.
